Molecular Insight Pharmaceuticals, Inc.·4/A

May 14, 6:37 PM ET

Wachholz James 4/A

4/A · Molecular Insight Pharmaceuticals, Inc. · Filed May 14, 2009

Insider Transaction Report

Form 4/AAmended
Period: 2009-05-12
Wachholz James
VP Reg. Affairs & Qual. Assur.
Transactions
  • Award

    Employee Stock Option (right to buy)

    2009-05-12+44,00044,000 total
    Exercise: $3.93Exp: 2019-05-12Common Stock (44,000 underlying)
Footnotes (2)
  • [F1]This amendment to Form 4 is being filed to correct the vesting schedule for 27,500 option shares reported on Form 4 so that all 44,000 option shares granted on May 12, 2009 by the Issuer to the reporting person shall vest over two years.
  • [F2]This option vests and becomes exercisable in two equal annual installments of 22,000 shares each on May 12, 2010 and May 12, 2011, respectively.

Documents

2 files
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION

  • EX-24.4A_286857

    POA DOCUMENT